Investor Presentation January 2022

CooperSurgical Office and surgical - Paragard IUD Business Highlights Only US FDA-approved 100% Hormone Free Intrauterine Device (IUD) Over 99% effective One simple active ingredient - Copper Lasts up to 10 years with Immediate Reversibility In office placement Opportunity to create top of mind awareness IUD Industry Highlights Paragard intrauterine copper contraceptive Non- Hormonal 17% Growth Drivers: ~$1.2B US Market Hormonal 83% Mid-single digit market growth Increased awareness and desire for a non- hormonal product 70% of women are concerned about hormones in birth control Opportunity to shift the U.S. market toward non-hormonal products CooperCompanies Source: Management estimates and independent market research Note: Paragard is included in CooperSurgical's office and surgical products category 18

View entire presentation